A novel companion diagnostic assay for BRAF V600E/K detection in melanoma: High clinical concordance of patient outcomes for trametinib and debrafenib treatment

被引：0
|
作者：
O'Donnell, L. [1 ]
Sweet, W. [1 ]
Lu, X. [1 ]
Meynier, F. [2 ]
Derome, A. [3 ]
Ganee, L. [3 ]
Poyet-Gelas, F. [3 ]
Martin, A.
Casey, M.
Kertesz, N. [4 ]
机构：
[1] BioMerieux Inc, Clin Affairs, Durham, NC USA
[2] BioMerieux Inc, BioMath, Grenoble, France
[3] BioMerieux Inc, R&D, Grenoble, France
[4] Response Genet Inc, Pharmaceut Liaison, Los Angeles, CA USA
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3720
引用
收藏
页码：S862 / S862
页数：1
相关论文
共 50 条
  • [1] High analytical concordance between a novel companion diagnostic assay and an IUO assay for BRAF V600E/V600K detection in melanoma
    O'Donnell, L.
    Sweet, W.
    Lu, X.
    Meynier, F.
    Derome, A.
    Ganee, L.
    Poyet-Gelas, F.
    Martin, A.
    Casey, M.
    Kertesz, N.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S27 - S27
  • [2] High precision of a novel companion diagnostic assay for the detection of BRAF V600E/V600K in formalin-fixed paraffin-embedded melanoma samples
    O'Donnell, L.
    Sweet, W.
    Lu, X.
    Meynier, F.
    Derome, A.
    Ganee, L.
    Poyet-Gelas, F.
    Martin, A.
    Casey, M.
    Kertesz, N.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S27 - S27
  • [3] Accuracy evaluation of a novel companion diagnostic method for BRAF V600E/V600K identification in GSK clinical trials
    O'Donnell, L.
    Sweet, W.
    Lu, X.
    Meynier, F.
    Derome, A.
    Ganee, L.
    Poyet-Gelas, F.
    Martin, A.
    Casey, M.
    Kertesz, N.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S26 - S27
  • [4] Trametinib plus dabrafenib for unresectable or metastatic melanoma with BRAF V600E or V600K mutations
    Abraham, Jame
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2014, 12 (07) : 234 - 235
  • [5] The safety and efficacy of cobimetinib for the treatment of BRAF V600E or V600K melanoma
    Amaral, Teresa
    Nouri, Noura
    Garbe, Claus
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (07) : 705 - 715
  • [6] Granulomatous nephritis and dermatitis in a patient with BRAF V600E mutant metastatic melanoma treated with dabrafenib and trametinib
    Jansen, Yanina J.
    Janssens, Peter
    Hoorens, Anne
    Schreuer, Max S.
    Seremet, Teofila
    Wilgenhof, Sofie
    Neyns, Bart
    MELANOMA RESEARCH, 2015, 25 (06) : 550 - 554
  • [7] Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K BRAF-Mutant Melanoma
    da Silva, Ines Pires
    Wang, Kevin Y. X.
    Wilmott, James S.
    Holst, Jeff
    Carlino, Matteo S.
    Park, John J.
    Quek, Camelia
    Wongchenko, Matthew
    Yan, Yibing
    Mann, Graham
    Johnson, Douglas B.
    McQuade, Jennifer L.
    Rai, Rajat
    Kefford, Richard F.
    Rizos, Helen
    Scolyer, Richard A.
    Yang, Jean Y. H.
    Long, Georgina V.
    Menzies, Alexander M.
    CLINICAL CANCER RESEARCH, 2019, 25 (04) : 1272 - 1279
  • [8] Encorafenib and binimetinib for the treatment of BRAF V600E/K-mutated melanoma
    Rose, A. A. N.
    DRUGS OF TODAY, 2019, 55 (04) : 247 - 264
  • [9] Comparison of BRAF V600E Mutation Detection Between Sanger Sequencing and Companion Diagnostic Methods
    Bender, R.
    Arnold, K.
    Ghazalpour, A.
    McGinniss, M.
    Gatalica, Z.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06) : 741 - 741
  • [10] A role for immunohistochemical detection of BRAF V600E prior to BRAF-inhibitor treatment of malignant melanoma?
    Lade-Keller, Johanne
    Kristensen, Lasse Sommer
    Riber-Hansen, Rikke
    Guldberg, Per
    Hansen, Lise Lotte
    Steiniche, Torben
    Hager, Henrik
    JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (08) : 723 - 725
12345